(Demupitamab)Biosimilar Reference Antibody-GS40175

货号：GS40175

Demupitamab is a humanized monoclonal antibody targeting the human epidermal growth factor receptor. As an anti-EGFR antibody, it is developed as a targeted therapy for solid tumors that overexpress or depend on EGFR signaling for growth and survival. Its mechanism is designed to block ligand binding and downstream oncogenic pathways, positioning it for potential use in cancers such as non-small cell lung cancer (NSCLC), colorectal cancer, head and neck squamous cell carcinoma, and others where EGFR plays a key pathogenic role.